Interferon-based treatment as adjuvant therapy for hepatitis C virus vaccine candidates against chronic infection
Therapeutic vaccine candidates against hepatitis C virus infection have demonstrated immunogenicity, but none of them have been able to induce complete viral elimination. Reviewed evidence shows hepatitis C virus-specific T cell exhaustion as a major obstacle for the immune containment of the virus....
Saved in:
Published in | Biotecnología Aplicada Vol. 28; no. 3; pp. 123 - 129 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Elfos Scientiae
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Therapeutic vaccine candidates against hepatitis C virus infection have demonstrated immunogenicity, but none of them have been able to induce complete viral elimination. Reviewed evidence shows hepatitis C virus-specific T cell exhaustion as a major obstacle for the immune containment of the virus. The possibility that hepatitis C virus-specific T cells may be rescued from exhaustion by interferon-based treatment makes this therapy a promising candidate to combine with hepatitis C virus-specific therapeutic vaccine interventions. This review summarizes the main effects of interferon-based therapy on hepatitis C virus-specific cellular immune response in chronic patients and, focuses on its potential to favorably impact the performance of therapeutic vaccine approaches for sustained viral clarification. |
---|---|
ISSN: | 1027-2852 |